Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
16,000
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Edwards Lifesciences Corp market cap is $58.56B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Edwards Lifesciences Corp 52 week high is $108.00 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Edwards Lifesciences Corp 52 week low is $74.66 as of November 22, 2026.
Edwards Lifesciences Corp stock price today is $101.85.
Edwards Lifesciences Corp stock price yesterday was $103.88.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Edwards Lifesciences Corp's P/E ratio is 59.32.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Edwards Lifesciences Corp P/B ratio is 5.3977.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Edwards Lifesciences Corp 50-day moving average is $92.22.